These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2749609)
61. Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation. Fouque F; Vargaftig BB Eur J Pharmacol; 1987 Mar; 135(2):211-8. PubMed ID: 3582495 [TBL] [Abstract][Full Text] [Related]
62. Presence of specific platelet-activating factor binding sites in the rat retina. Thierry A; Doly M; Braquet P; Cluzel J; Meyniel G Eur J Pharmacol; 1989 Apr; 163(1):97-101. PubMed ID: 2545464 [TBL] [Abstract][Full Text] [Related]
63. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo. Yue TL; Rabinovici R; Farhat M; Feuerstein G J Lipid Mediat; 1991; 3(1):13-26. PubMed ID: 1768837 [TBL] [Abstract][Full Text] [Related]
64. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Stewart AG; Dusting GJ Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058 [TBL] [Abstract][Full Text] [Related]
65. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function. Dent G; Ukena D; Chanez P; Sybrecht G; Barnes P FEBS Lett; 1989 Feb; 244(2):365-8. PubMed ID: 2537761 [TBL] [Abstract][Full Text] [Related]
66. Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man. Brecht HM; Adamus WS; Heuer HO; Birke FW; Kempe ER Arzneimittelforschung; 1991 Jan; 41(1):51-9. PubMed ID: 1646613 [TBL] [Abstract][Full Text] [Related]
67. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor. Chang SW; Ohara N; Kuo G; Voelkel NF Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951 [TBL] [Abstract][Full Text] [Related]
68. The involvement of platelet-activating factor in thrombocytopenia and follicular rupture during gonadotropin-induced superovulation in immature rats. Li XM; Sagawa N; Ihara Y; Okagaki A; Hasegawa M; Inamori K; Itoh H; Mori T; Ban C Endocrinology; 1991 Dec; 129(6):3132-8. PubMed ID: 1954894 [TBL] [Abstract][Full Text] [Related]
69. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist. Yue TL; Gleason MM; Gu JL; Lysko PG; Hallenbeck J; Feuerstein G J Pharmacol Exp Ther; 1991 Apr; 257(1):374-81. PubMed ID: 1850473 [TBL] [Abstract][Full Text] [Related]
70. Biosynthesis of platelet activating factor (PAF) by an osteosarcoma cell line (UMR 106). Wasil M; Harvey W; Murphy CT; Hopps RM Biochem Soc Trans; 1991 Apr; 19(2):184S. PubMed ID: 1889567 [No Abstract] [Full Text] [Related]
71. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. Sweatt JD; Schwartzberg MS; Frazer M; Cragoe EJ; Blair IA; Reed PW; Limbird LE Circ Res; 1987 Nov; 61(5 Pt 2):II6-11. PubMed ID: 2822286 [TBL] [Abstract][Full Text] [Related]
72. A PAF antagonist blocks antigen-induced airway hyperresponsiveness and inflammation in sheep. Solèr M; Sielczak MW; Abraham WM J Appl Physiol (1985); 1989 Jul; 67(1):406-13. PubMed ID: 2759969 [TBL] [Abstract][Full Text] [Related]
73. Stimulation of degranulation from human eosinophils by platelet-activating factor. Kroegel C; Yukawa T; Dent G; Venge P; Chung KF; Barnes PJ J Immunol; 1989 May; 142(10):3518-26. PubMed ID: 2541198 [TBL] [Abstract][Full Text] [Related]
74. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Pretolani M; Lefort J; Malanchère E; Vargaftig BB Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247 [TBL] [Abstract][Full Text] [Related]
76. 1,25-(OH)2 vitamin D-3 enhances Paf-stimulated calcium mobilization in U937 cells by expression of specific Paf binding sites. Aepfelbacher M; Korth R; Weber PC Biochim Biophys Acta; 1990 Feb; 1051(2):179-84. PubMed ID: 2155666 [TBL] [Abstract][Full Text] [Related]
77. Pharmacological effect of nitroprusside on platelet aggregation. Parrish PR; Larson DF J Extra Corpor Technol; 1999 Dec; 31(4):162-8. PubMed ID: 10915472 [TBL] [Abstract][Full Text] [Related]
78. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. Rabinovici R; Yue TL; Farhat M; Smith EF; Esser KM; Slivjak M; Feuerstein G J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560 [TBL] [Abstract][Full Text] [Related]
79. Interaction between the effects of 5-hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog. McAuliffe SJ; Snow HM; Cox B; Smith CC; Noble MI Br J Pharmacol; 1993 Jun; 109(2):405-10. PubMed ID: 8358542 [TBL] [Abstract][Full Text] [Related]
80. Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. Flores NA; Sheridan DJ Br J Pharmacol; 1990 Nov; 101(3):734-8. PubMed ID: 2076489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]